Researchers are launching a new study to determine how individuals with
rheumatoid arthritis evaluate improvements in disease symptoms during treatment.
Trial organizers said such a trial is needed because physicians generally
evaluate the health of patients with rheumatoid arthritis by physically measurable
criteria, but little attention is given to whether treatment results are meaningful
to patients. Using patient-based criteria might help physicians determine
if a new treatment is likely to be considered helpful by the patient.
Hampton T. Rheumatoid Arthritis Trial. JAMA. 2004;292(12):1419. doi:10.1001/jama.292.12.1419-c